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PURPOSE. Mutations in six genes have been associated with achromatopsia (ACHM): CNGA3,
CNGB3, PDE6H, PDE6C, GNAT2, and ATF6. ATF6 is the most recent gene to be identified,
though thorough phenotyping of this genetic subtype is lacking. Here, we sought to test the
hypothesis that ATF6-associated ACHM is a structurally distinct form of congenital ACHM.
METHODS. Seven genetically confirmed subjects from five nonconsanguineous families were
recruited. Foveal hypoplasia and the integrity of the ellipsoid zone (EZ) band (a.k.a., IS/OS)
were graded from optical coherence tomography (OCT) images. Images of the photoreceptor
mosaic were acquired using confocal and nonconfocal split-detection adaptive optics
scanning light ophthalmoscopy (AOSLO). Parafoveal cone and rod density values were
calculated and compared to published normative data as well as data from two subjects
harboring CNGA3 or CNGB3 mutations who were recruited for comparative purposes.
Additionally, nonconfocal dark-field AOSLO images of the retinal pigment epithelium were
obtained, with quantitative analysis performed in one subject with ATF6-ACHM.
RESULTS. Foveal hypoplasia was observed in all subjects with ATF6 mutations. Absence of the
EZ band within the foveal region (grade 3) or appearance of a hyporeflective zone (grade 4)
was seen in all subjects with ATF6 using OCT. There was no evidence of remnant foveal cone
structure using confocal AOSLO, although sporadic cone-like structures were seen in
nonconfocal split-detection AOSLO. There was a lack of cone structure in the parafovea, in
direct contrast to previous reports.
CONCLUSIONS. Our data demonstrate a near absence of cone structure in subjects harboring
ATF6 mutations. This implicates ATF6 as having a major role in cone development and
suggests that at least a subset of subjects with ATF6-ACHM have markedly fewer cellular
targets for cone-directed gene therapies than do subjects with CNGA3- or CNGB3-ACHM.
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Achromatopsia (ACHM) is an autosomal recessive conditionthat is characterized by a lack of cone photoreceptor
function. Subjects present at birth or early infancy with
nystagmus, reduced visual acuity, photoaversion, and reduced
or absent color vision.1,2 Disease-causing sequence variants in
the genes encoding the alpha and beta subunits of the cone-
specific cyclic nucleotide gated ion channel (CNGA3 and
CNGB3, respectively) account for approximately 70% of all
cases of ACHM,3 although variants in genes encoding for other
components of the cone phototransduction pathway (GNAT2,
PDE6H, PDE6C)4–6 have also been associated with ACHM.
Advances in genetic testing have resulted in discovery of a
genetic basis for nearly all patients with ACHM.7 Any remaining
molecularly unconfirmed cases of ACHM may actually be
misdiagnosed cases of atypical cone-rod dystrophy. That said,
additional genes cannot be ruled out. For example, mutations in
ATF6 were recently identified in some subjects with ACHM
who were negative for mutations in the aforementioned
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phototransduction genes.8–11 The ATF6 protein encodes an
endoplasmic reticulum (ER) localized transcription factor that
helps maintain ER homeostasis, as part of the unfolded protein
response (UPR). As one of three transmembrane proteins that
regulate the UPR, ATF6 is activated upon ER stress to
transcriptionally upregulate ER chaperones and ER protein
folding enzymes that help alleviate ER stress and restore
cellular homeostasis.12–14 Disease-causing sequence variants in
ATF6 result in dysfunction of this critical signaling pathway.
This seems especially detrimental to photoreceptor cells,
which are among the most metabolically active cells in the
human body.15,16
As gene replacement therapy efforts in ACHM target cone
photoreceptors, it is important to fully understand how these
cones are affected by a given genotype. A variety of
noninvasive imaging tools are available for examining retinal
structure, and these have already been applied extensively to
the more common forms of ACHM.17–21 Optical coherence
tomography (OCT) provides visualization of retinal lamination,
enabling measurements of retinal layer thickness and intensity.
Of particular interest are the hyperreflective (ellipsoid zone,
EZ, and interdigitation zone, IZ) and hyporeflective (outer
nuclear layer, ONL) bands associated with the photorecep-
tors.22,23 In subjects with CNGA3- or CNGB3-associated ACHM
(abbreviated CNGA3-ACHM and CNGB3-ACHM, respectively)
the EZ band at the fovea is disrupted or absent in
approximately 68% of cases.20,21 The thickness of the ONL is
also significantly reduced in CNGA3- and CNGB3-ACHM,
although there is substantial variability among subjects.20,21,24
Another imaging tool—adaptive optics scanning light ophthal-
moscopy (AOSLO)—enables noninvasive, cellular resolution
imaging of the rod and cone photoreceptor mosaic. In subjects
with CNGA3- or CNGB3-ACHM, there is an absence of normal
waveguiding cone photoreceptors when imaged with the
confocal modality of AOSLO,17,21 although the rod photore-
ceptors appear normal (Patterson E, et al. IOVS 2018;59:ARVO
E-Abstract 652). Using a nonconfocal split-detection AOSLO
technique, extensive remnant photoreceptor inner segment
structures have been observed in these subjects that coincide
spatially with the non-waveguiding cones seen in the confocal
images.21,25
To date, the imaging findings in ATF6-associated ACHM
(ATF6-ACHM) include bilateral loss of the foveal reflex on
fundus examination,8 and variable abnormalities in fundus
autofluorescence imaging.9 In addition, foveal hypoplasia with
minimal foveal pit formation has been observed in all subjects
with ATF6-ACHM to date.9,10 A single study used a commercial
prototype AOSLO to image one subject with ATF6-ACHM,9 and
reported supranormal cone density outside the central fovea.
This is in stark contrast to previous reports in patients with
CNGA3- or CNGB3-ACHM,17,19,21 raising questions about
possible genotype-dependent differences in cone structure as
well as highlighting the need to more fully examine cone
structure in additional subjects with ATF6-ACHM. Here, we
sought to further examine retinal structure in ATF6-ACHM
using OCT and AOSLO.
METHODS
Subjects
Seven genetically confirmed subjects from five nonconsangui-
neous families (MM_0044 and MM_0043, and MM_0147 and
MM_0152 are siblings, respectively) were recruited through
one of four sites (Table 1). Informed consent was obtained
from all participants. Three subjects were imaged at the
Medical College of Wisconsin and four subjects were imaged at
Moorfields Eye Hospital, London. Data from two additional
non-ATF6 ACHM subjects, one CNGA3-ACHM and one CNGB3-
ACHM, were included for comparison (see Table 1 for details).
This study followed the tenets of the Declaration of Helsinki
and was approved by the institutional review boards at the
Medical College of Wisconsin (PRO17439 and PRO30741) and
University College London/Moorfields Eye Hospital (UCL/
MEH).
Genetics
All seven subjects had genetic sequencing performed, with five
of the subjects previously reported in the literature (Table
1).9,10 One unreported mutation was found (TM_11446) that
deleted 1637 nucleotides and leads to a deletion of exons 2 and
3 of the ATF6 gene. This deletion is in the transcription
TABLE 1. Subject Demographics
Subject Sex Age Gene Genotype
Axial Length, mm
Right Eye Left Eye
JC_10069* M 18 CNGA3 c.847C>T / p.Arg283Trp 23.13 23.59
c.542A>G / p.Tyr181Cys
JC_10232† M 18 CNGB3 c.1148delC / p.Thr383Ile fs*13, homozygous 26.22 27.06
MM_0043‡ F 49 ATF6 c.970C>T / p.Arg324Cys, homozygous 24.33 24.38
MM_0044‡ F 44 ATF6 c.970C>T / p.Arg324Cys, homozygous 20.60 20.51
MM_0147‡ F 25 ATF6 c.1187þ5G>C / p.Asn366His fs*12, homozygous 22.59 22.58
MM_0152‡ F 26 ATF6 c.1187þ5G>C / p.Asn366His fs*12, homozygous 23.08 23.12
AV_10962 F 25 ATF6 c.1699T>A / p.Tyr567Asn, homozygous 22.60 22.55
TM_11446 M 10 ATF6 c.970C>T / p.Arg324Cys 24.42 24.51
c.(82þ1_83-2)_(247þ1_248-1_del)§
JC_11438jj F 6 ATF6 c.1126C>T / p.Arg376Ter 19.45 19.34
c.1533þ1G>C
F, female; M, male.
* Subject previously reported in multiple studies.25,39
† Subject previously reported in multiple studies as ACHM-001-CEI-001.21,47
‡ Subject reported by Kohl et al.9
§ This is a novel deletion in exons 2 and 3, which removes part of the acidic activator domain of ATF6 required for its transcriptional activator
properties.
jj Subject reported by Xu et al.10
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activation region within the cytosolic domain, and thus would
be predicted to be deleterious (though no in silico predictions
are available for this deletion). Familial testing confirmed that
this deletion was in trans to the other mutation in this subject
(c.970C>T / p.Arg324Cys), which has been previously
reported in other patients.9
OCT Imaging and Analysis
Prior to imaging, the combination of tropicamide (1%) and
phenylephrine hydrochloride (2.5%) was used for cycloplegia
and pupillary dilation in all but two subjects who were
children, and Cyclomydril (Alcon Laboratories, Fort Worth, TX,
USA) was used instead. Bioptigen SD-OCT (Leica Microsystems,
Wetzlar, Germany) was used to acquire volume and horizontal
line scans at the fovea. Horizontal line scans were obtained
with a nominal scan length of 7 or 8 mm and volume scans
were 731 and 737 mm in scan length. Images in both eyes of
all subjects were acquired, with the exception of JC_11438 in
whom only the right eye was imaged. The OCT images were
processed using ImageJ,26 and between 7 and 29 individual B-
scans were registered and averaged to improve signal-to-noise
ratio for subsequent analysis, as previously described.27 Foveal
line scans were graded for EZ disruption by one observer
(R.R.M.) using a previously established grading system.20,21 In
summary, grade 1 corresponds to a continuous EZ band, grade
2 is EZ disruption, grade 3 is the absence of the EZ band, grade
4 is the appearance of a hyporeflective zone, and grade 5 is
outer retinal atrophy. Foveal ONL thickness—defined as the
distance between the inner limiting membrane and external
limiting membrane (ELM) in the case of complete foveal
excavation or the distance between the outer plexiform layer
and ELM in the case of incomplete foveal excavation20,21—was
evaluated using OCT Reflectivity Analytics (ORA) soft-
ware.24,28 Foveal hypoplasia, defined as the presence of one
or more inner retinal layers through the fovea, was also
assessed.18,20,29 Axial length measurements (IOL Master; Carl
Zeiss Meditec, Dublin, CA, USA) were obtained in both eyes of
all subjects for use in deriving the lateral scale of the OCT and
AOSLO retinal images.
AOSLO Imaging and Analysis
High-resolution imaging was attempted in all seven subjects
using one of three previously described custom-built AOSLO
devices.25,30,31 Videos were acquired at the fovea in addition to
a strip extending from the fovea out to 108 in the temporal
direction. Since the system uses optical scanners to capture
videos, there is inherent distortion, which is made worse by
involuntary eye movements like nystagmus seen in ACHM
subjects. The AOSLO videos were registered and averaged32 to
an automatically selected reference frame.33 This method
increases the signal-to-noise ratio of the resulting processed
images. Three AOSLO modalities (confocal, split-detection, and
dark-field) are acquired simultaneously,25,34 and therefore, at
the same location. The best-quality processed images were
determined manually and imported into a program that
automatically aligned the individual AOSLO images from each
location to create a larger montage spanning the region of the
retina that was imaged.35 Upon completion, the images were
entered into Adobe Photoshop (Adobe Systems, Inc., San Jose,
CA, USA) where alignment of each image was manually
checked and adjusted as needed. Montages of different fields
of view (ranging from 1.08 3 1.08 to 3.08 3 3.08) were then
scaled and combined into a single montage for each subject for
analysis.
Two of the seven subjects had montages that extended to
approximately 108 in the temporal direction with sufficient
image quality to determine cell counts across the imaged
region. Peak cone density is typically used to aid determina-
tion of eccentricity; however, subjects with ATF6-ACHM have
minimal, if any, discernable cones in the fovea so peak cone
density could not be calculated. The foveal center was
therefore identified as the geometric center of the foveal
lesion, found from marking the outermost edges in the
vertical and horizontal directions. Measurements of eccen-
tricity were referenced to this location. Regions of interest,
1003 100 lm in size, were selected at 58 and 108 temporal to
the foveal center using semiautomated cone counting
software (Translational Imaging Innovations).36 In ATF6-
ACHM, all objects that represented small, round structures
with an approximate Gaussian reflectivity profile within the
region of interest were counted in the confocal modality and
used to estimate cell densities.19 In CNGA3- and CNGB3-
ACHM the reflective structures seen in the confocal modality
were representative of rod photoreceptors17,21; therefore the
hyporeflective structures surrounded by hyperreflective rods
were counted to derive cone density measurements at both
eccentricities for comparison to the cell density counts of
ATF6-ACHM.
Statistics
Data analysis included statistical tests performed using Prism
version 7.0 (GraphPad Software, La Jolla, CA, USA). Normality
was assessed using the Shapiro-Wilk normality tests for all data
sets. Nonparametric tests were used to assess nonnormally
distributed data.
RESULTS
Disrupted Foveal Anatomy Observed in All
Subjects With ATF6-ACHM
Foveal hypoplasia was evident in OCT images for all subjects
(Fig. 1), and is consistent with previous reports of ATF6-
ACHM.9 All 21 reported ATF6-ACHM subjects (including those
reported here) show foveal hypoplasia,9,10 which is markedly
different when compared to the 97/146 previously reported
subjects with CNGA3- and CNGB3-ACHM (P < 0.0001, Fisher’s
exact test).17,20,21,37,38 While foveal hypoplasia is observed in
subjects with CNGA3- and CNGB3-ACHM,20 the incomplete
foveal development consistently seen in ATF6-ACHM is unusual
in comparison to the other genetic causes. In addition,
disrupted foveal lamination was observed in all subjects; either
grade 3 (Fig. 1, top row) or grade 4 (Fig. 1, bottom row) EZ
disruption.20 Interestingly, there was also evidence of other
disorganization seen at the fovea; with hyperreflective
structures of unknown origin visible within the ONL of two
subjects, MM_0043 and MM_0044, and what might be Mu¨ller
glial cells below the ELM in MM_0152 and JC_11438 (Fig. 1).
Foveal ONL thickness was highly variable in the seven cases
studied, ranging from 39.22 to 174.04 lm, and the mean 6 SD
foveal ONL thickness for ATF6-ACHM was 95.23 6 41.88 lm.
As shown in Figure 2, this was slightly lower than previously
reported values for controls (110.60 6 15.67 lm).24 However,
due to the small number of subjects with ATF6-ACHM and the
larger range in their ONL thickness, this was not significant (P
¼ 0.3215, Dunn’s multiple comparisons test). The ONL
thickness in the subjects with ATF6-ACHM, while greater,
was not significantly different from previously reported values
for CNGA3- (74.18 6 21.80 lm; P ¼ 0.6232, Dunn’s multiple
comparisons test)39 or CNGB3-ACHM (74.15 6 15.96 lm; P¼
0.5158, Dunn’s multiple comparisons test).21
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Central Foveal Lesions With Ambiguous Structures
Seen in AOSLO
We were not able to process or analyze the AOSLO images from
two of our subjects (JC_11438 and MM_0043), due to poor
image quality. However, four of the remaining five subjects had
successful imaging sessions that allowed for construction of a
complete foveal montage (five eyes total). Despite variations in
image quality, a central foveal lesion, denoted by a distinct,
dark ring in confocal AOSLO (Fig. 3), was observed in all eyes
imaged. A fifth subject (AV_10962) had good image quality in
both eyes, and while the presence of a foveal lesion could be
confirmed, the montages were incomplete and did not include
the entire lesion. Although sporadic structures were observed
within all lesions using split-detector AOSLO (Figs. 3, 4), their
appearance was highly variable and distinct from those seen in
images of CNGA3- or CNGB3-ACHM. In the CNGA3 and
CNGB3 forms of ACHM, a clear foveal cone mosaic can be
visualized using split-detection AOSLO (Figs. 3, 4), and in some
subjects the mosaic can be contiguous.21,25,39 Using confocal
AOSLO, the majority of features at the fovea of ATF6-ACHM
seemed to be retinal pigment epithelial (RPE) cells, observed as
hyporeflective, hexagonal structures that did not align to any
distinct features in the split-detection modality, but rather
directly aligned with the dark-field RPE mosaic (Fig. 4,
MM_0152). However, occasional isolated cone-like structures
were observed in the split-detection images (Fig. 4, white
arrows). Within the lesion of MM_0147, large, circular
structures were visible in the nonconfocal split-detection
images (Fig. 4), which could originate from swollen, non-
waveguiding cones, perhaps in the process of degeneration, or
from RPE cells. Additionally, the ambiguous structures congre-
gated around the edge of the lesion in MM_0044, also seen in
the nonconfocal split-detection images, could represent rods or
cones (Fig. 4). These observations are in keeping with a
general absence of foveal cone structure in ATF6-ACHM.
Subject TM_11446 had very unusual dark-field images.
Punctate structures were seen throughout the foveal region
(Fig. 4) that were unlike anything we have observed in the
other subjects with ATF6-ACHM or any previous subjects with
CNGA3- or CNGB3-ACHM. We analyzed the density of these
structures at three regions of interest (Fig. 5). The densities
were 5898, 5402, and 4888 cells/mm2, at 18, 28, and 38
FIGURE 1. Disrupted foveal structure in ATF6-ACHM visualized with SD-OCT. An SD-OCT scan at the fovea of a subject with normal vision is shown
for reference. Severe foveal hypoplasia (persistent inner retinal layers at the fovea) was observed in all seven subjects. All subjects showed
disruption of the EZ, either as a grade 3 (top three subjects) or a grade 4 (bottom four subjects). In contrast, subjects with CNGA3- or CNGB3-ACHM
have a more variable EZ phenotype, with all five EZ grades having been observed.20,21 Scale bar: 100 lm.
FIGURE 2. Variably reduced ONL thickness in ATF6-ACHM. Box plots
show the median ONL thickness (dashed horizontal line) and 25th
and 75th quartile (solid horizonal line) for each group of subjects. The
error bars represent the minimum and maximum values within each
group. A Kruskal-Wallis test revealed a significant difference between
groups (P < 0.0001), and Dunn’s multiple comparisons test was used
to examine difference between specific pairs of groups. Individual P
values are listed on the graph for clarity. The previously published
CNGA3-39 and CNGB3-ACHM subjects21 have reduced ONL thickness
compared to the published control data.24 The subjects with ATF6-
ACHM had thicker ONL compared to the CNGA3 and CNGB3 data, but
were not significantly different from the controls.
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FIGURE 3. Foveal lesions in ATF6-ACHM as seen with AOSLO. Montages of the fovea are shown in both confocal (left) and split-detection (right)
modalities. While subjects with CNGA3- or CNGB3-ACHM generally have a hyporeflective-appearing fovea with confocal AOSLO,21 the subjects with
ATF6-ACHM showed an elliptical hyperreflective lesion at the fovea. The structure within this lesion was reminiscent of RPE, as has been reported
in subjects with advanced cone-rod dystrophy.57 On split detection, the subject with CNGB3-ACHM showed numerous remnant cone structures
within the foveal region, and the extent of remnant cone structure has been reported to vary across subjects by nearly 8-fold.21 In contrast, subjects
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eccentricity, respectively. These values are in excellent
agreement with previously reported values for RPE cell
densities at similar retinal locations from histology40,41 and in
vivo AOSLO imaging.34,42–44 While this is suggestive of an RPE
origin for these structures, the appearance of the structures
seen here is unlike any of the published AOSLO images of RPE
cells, regardless of the modality used.
Parafoveal Photoreceptor Mosaic in ATF6-ACHM
Has Density Consistent With the Normal Rod, Not
Cone, Mosaic
Two subjects (MM_0044, MM_0147) had stable fixation and
good image quality that enabled reliable imaging and parafo-
veal analysis in the temporal retina. In the CNGA3 and CNGB3
forms of ACHM, both rods and cones can be easily
distinguished.21,25,39 In these subjects, the parafoveal cones
appear dark (i.e., non-waveguiding) on confocal AOSLO
surrounded by the smaller hyporeflective rods, though their
inner segments can be visualized in split-detection AOSLO (Fig.
6). In contrast, both ATF6-ACHM individuals had a contiguous
mosaic of cells of uniform size on both the confocal and split-
detector AOSLO images (Fig. 6). When the parafoveal cell
counts of MM_0044 and MM_0147 were compared to normal
rod and cone density values from imaging and histology studies
at comparable eccentricities,45,46 they were more similar to
normal rod density (Table 2). This is consistent with an
absence of cone structure in the parafovea of these two
subjects with ATF6-ACHM.
DISCUSSION
Kohl et al.9 suggested that a poorly formed or absent foveal pit
may be a hallmark of ATF6-ACHM, which is confirmed by the
high-resolution data presented here. Foveal hypoplasia was
observed in all seven subjects with ATF6-ACHM, again
consistent with previous reports.9,10 The increased prevalence
of hypoplasia may contribute to the observed ONL differences
reported in Figure 2. In addition, only grade 3 and grade 4 EZ
disruption was observed in direct contrast to CNGA3- and
CNGB3-ACHM, in which all five EZ grades were ob-
served.20,21,47 In previous work, 2% to 15% of subjects with
CNGA3- and CNGB3-ACHM had grade 3 EZ disruption and 24%
to 31% had grade 4.20,21,24 Further disorganization was
observed at the fovea including hyperreflectivity of the ONL
(MM_0043, MM_0044) and apparent thickening of the ELM
(MM_0152, JC_11438). These findings suggest that the normal
foveal development is significantly disrupted in individuals
with ATF6-ACHM, but it remains an unanswered question as to
what aberrant development is taking place. Furthermore,
nonconfocal split-detection AOSLO allowed us to observe
structures in the foveal region that appear to be RPE cells from
the appearance in the dark-field AOSLO, although the
possibility of cones being present cannot be completely
discounted. Lastly, we examined the parafoveal photoreceptor
mosaic. Kohl et al.9 reported that individuals with ATF6-ACHM
lacked cones at the fovea but had supranormal cone densities
outside the foveal region. However, in contrast, we found a
general absence of cones at the fovea and a complete absence
of cones in the parafoveal regions. Although cell counts were
higher in the parafovea, we hypothesize that these cells are
rods rather than cones, based on both density and relative size.
Commercially available AO systems, such as the one used in the
earlier study,9 are typically geared toward more clinical use.
These systems frequently have limited resolution making it
difficult to disambiguate rod from cone structure and to
FIGURE 4. Reduced foveal cone structure in ATF6-ACHM as seen with
AOSLO. Images are numbered according to the labels in Figure 3, and
the three images for each subject were acquired simultaneously and are
spatially coregistered. The CNGB3 image shows many remnant inner
segments on split detection, though these cones are not waveguiding
normally, resulting in a hyporeflective confocal image. In the subjects
with ATF6-ACHM there were isolated locations of remnant cone
structures observed in the split-detection images (e.g., arrows [6, 10]),
though they are very different in frequency than what is typically seen
in subjects with CNGA3- and CNGB3-ACHM.21,39 Within the fovea of
subjects with ATF6-ACHM, the hyporeflective structure observed with
confocal imaging aligned with structure in the dark-field image in many
cases (see MM_0152 and MM_0044 for particularly clear examples).
These images are consistent with the RPE mosaic and a general absence
of cone structure (a small group of RPE cells are outlined in the
confocal and dark-field images for MM_0152). One subject (TM_11446)
had large reflective structures in the dark-field image, in stark contrast
to the other subjects as well as previously published dark-field
images.34 Scale bar: 25 lm.
with ATF6-ACHM had few (if any) cones visible in the split-detection images. For example, MM_0044 had a sparse array of presumed cones on the
border of the foveal lesion, while MM_0147 had a few small patches of inner segments that appeared enlarged compared to the CNGB3-ACHM
retina. Numbered (1–10) squares represent locations of the images shown in Figure 4. Scale bar: 200 lm.
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reliably image foveal cones.48,49 As well, many prior studies
erroneously assume that all reflective dots in the AO-flood or
AOSLO images represent cone photoreceptors. Thus, caution
should be used when interpreting such data. Nonconfocal
imaging modalities like the split-detection AOSLO used here
can help define remnant cone structure without being reliant
on intact waveguiding properties of the cell.25,50–52 It is
important to note that next-generation commercial systems are
improving significantly, with many incorporating nonconfocal
modalities,53–55 so interpretation of AOSLO images should only
improve.
When the peripheral and foveal appearance on AOSLO are
taken together, ATF6-ACHM represents a unique phenotype.
The most frequently observed phenotype in CNGA3- and
CNGB3-ACHM is the presence of dark, non-waveguiding cones
in confocal images corresponding to remnant inner segment
structures in split-detection images, albeit highly variable in
density.21,39 Another AOSLO phenotype has been reported in
FIGURE 5. Unusual dark-field AOSLO images in a subject with ATF6-ACHM. Shown are parafoveal images from the left eye of subject TM_11446.
Images were collected at 18 (A–C), 28 (D–F), or 38 (G–I) from the foveal center. Simultaneous confocal (A, D, G), split-detector (B, E, H), and dark-
field images (C, F, I) were acquired at each location. The smaller reflective structures in the confocal images are likely rods, based on their small size
and corresponding absence of cone inner segment structure in the split-detector images (see Figs. 3 and 6 for comparison to CNGA3- and CNGB3-
ACHM). The dark-field images reveal a relatively contiguous mosaic of cell-like structures, which we propose may be RPE in origin. The densities
were 5898, 5402, and 4888 cells/mm2 at 18, 28, and 38 eccentricity, respectively. These values are consistent with ex vivo and in vivo estimates of
RPE cell density at similar retinal locations (see text). Scale bar: 50 lm.
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GNAT2-ACHM, as these individuals have contiguous foveal
cone mosaics with normal-like waveguiding behavior,19 con-
sistent with reports of remnant cone function in some patients
with GNAT2 mutations.56 However, what has been observed
here in ATF6-ACHM is certainly unique as there is a foveal
lesion with a general absence of cones in addition to solely rod
photoreceptors in the parafovea. That said, the preserved (or
even increased) ONL thickness in some subjects with ATF6-
ACHM (Fig. 2) is paradoxical given the absence of cone
structure on AOSLO. This could be due to preserved cone
nuclei or altered morphology of the remaining rod nuclei, or it
could be an artifact caused by the severe hypoplasia.
Here, the clear visibility of the foveal RPE mosaic with
confocal AOSLO in some of the subjects with ATF6-ACHM is
also consistent with a general absence of foveal cone structure
in these retinas. The RPE mosaic appearance has been reported
by Scoles et al.34 in central serious retinopathy when the retina
is detached and cross-talk between the photoreceptor layer
and RPE is minimized, which in turn allows for a clear
visualization of the RPE hexagonal mosaic. Furthermore, it has
also been observed by Roorda et al.57 in cone dystrophy where
the photoreceptors are eliminated, leaving the RPE visible.
While dark-field AOSLO images also revealed a hexagonal RPE
mosaic in some of our subjects that was similar in appearance
to previously published data from multiple AOSLO modali-
ties,34,42–44 the appearance of the dark-field AOSLO images in
subject TM_11446 is unlike anything we have seen in imaging
hundreds of patients with inherited retinal degenerations. It is
difficult to speculate why these presumed RPE cells are so
different in appearance or whether this has anything to do
with the specific (and unique) ATF6 mutation in this subject.
While we cannot confirm the cellular identity of these unusual
structures, further imaging of this patient using ICG-AOSLO,43
NIRAF- or SWAF-AOSLO,44 or even AO-OCT58,59 may aid in
interpretation.
There are important limitations to the present study. First,
the parafoveal data demonstrating a lack of cone structure are
based on data from just two of our subjects, and the qualitative
central foveal analysis was based on just five of our subjects. As
such, whether these observations are generalizable to all
subjects with ATF6-ACHM remains unknown. That said, the
striking difference we observed is consistent with such an
interpretation. More subjects should be examined to assess the
full range of retinal/photoreceptor structure associated with
these mutations. It may also be of interest to use AOSLO to
examine individuals with ATF6-associated cone-rod dystro-
phy11 to look for cellular-resolution phenotypic differences
with other forms of cone-rod dystrophy. Furthermore, the in
vivo nature of these studies precludes definitive identification
of the cellular structures in the images; however, we believe
that the interpretation we have provided represents the most
likely scenario.
This is the first in-depth analysis of retinal architecture in
ATF6-ACHM, which is molecularly different from the other five
cone phototransduction-related genetic forms of ACHM, and so
it should not be surprising that the retinal phenotype starkly
varies from the other forms. However, one of the more
puzzling aspects of this condition is why the defect appears to
be specific to cones, given the ubiquitous expression of ATF6.
The similarity of phenotype across the subjects of varying ages
supports the cone defect as being congenital and not
progressive, though longitudinal studies are needed to confirm
this. The absence (or severe reduction) of cone structure in
ATF6-ACHM suggests that these patients may not respond
positively to cone-directed gene replacement therapy. If there
is a sparse array of remnant cones in some subjects, additional
strategies involving ATF6-activating small molecules could be
explored,60–62 as current methods of gene delivery via
subretinal injection likely result in some photoreceptor
damage. It seems more likely that alternative approaches, such
as cell replacement therapy, may be worth pursuing for these
patients. The ability to quantify cone structure on an
FIGURE 6. Altered parafoveal cone structure in ATF6-ACHM. In the
subject with CNGA3-ACHM, the cones had reduced or absent
reflectivity on confocal AOSLO (top rows at each eccentricity) but
could be identified by the surrounding rod mosaic. These ‘‘dark’’ cones
aligned with remnant inner segments seen in the corresponding split-
detection image (bottom rows at each eccentricity). In contrast,
subjects with ATF6-ACHM had a mosaic of uniformly sized structures
on both confocal and split-detection AOSLO. These cells were much
smaller than the remnant cones in the CNGA3 retina, being more
similar in size to the rod photoreceptors. In addition, an analysis of cell
density showed that the ATF6 parafoveal mosaic was consistent with
normal rod density as opposed to cone density (see Table 2). Taken
together, this suggests that subjects with ATF6-ACHM have minimal, if
any, cone photoreceptors in the parafoveal region. Scale bar: 25 lm.
TABLE 2. Parafoveal Cell Counts
Subject
Cell Density, Cells/mm2
58T 108T
MM_0147 103,433 84,009
MM_0044 85,406 98,161
JC_10069 (CNGA3), cones 7,454 6,726
Normal rod density* 80,000 125,000
Normal cone density* 15,000 10,000
* Approximate values from prior histology45 and imaging studies.46
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individualized basis should be valuable for selecting the best
approach for a given patient as well as monitoring structural
changes following intervention.
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